Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters

Country/Region as subject
Publication year range
1.
PLoS Med ; 13(8): e1002055, 2016 08.
Article in English | MEDLINE | ID: mdl-27483136

ABSTRACT

BACKGROUND: Antimicrobial resistance is a major issue in the Shigellae, particularly as a specific multidrug-resistant (MDR) lineage of Shigella sonnei (lineage III) is becoming globally dominant. Ciprofloxacin is a recommended treatment for Shigella infections. However, ciprofloxacin-resistant S. sonnei are being increasingly isolated in Asia and sporadically reported on other continents. We hypothesized that Asia is a primary hub for the recent international spread of ciprofloxacin-resistant S. sonnei. METHODS AND FINDINGS: We performed whole-genome sequencing on a collection of 60 contemporaneous ciprofloxacin-resistant S. sonnei isolated in four countries within Asia (Vietnam, n = 11; Bhutan, n = 12; Thailand, n = 1; Cambodia, n = 1) and two outside of Asia (Australia, n = 19; Ireland, n = 16). We reconstructed the recent evolutionary history of these organisms and combined these data with their geographical location of isolation. Placing these sequences into a global phylogeny, we found that all ciprofloxacin-resistant S. sonnei formed a single clade within a Central Asian expansion of lineage III. Furthermore, our data show that resistance to ciprofloxacin within S. sonnei may be globally attributed to a single clonal emergence event, encompassing sequential gyrA-S83L, parC-S80I, and gyrA-D87G mutations. Geographical data predict that South Asia is the likely primary source of these organisms, which are being regularly exported across Asia and intercontinentally into Australia, the United States and Europe. Our analysis was limited by the number of S. sonnei sequences available from diverse geographical areas and time periods, and we cannot discount the potential existence of other unsampled reservoir populations of antimicrobial-resistant S. sonnei. CONCLUSIONS: This study suggests that a single clone, which is widespread in South Asia, is likely driving the current intercontinental surge of ciprofloxacin-resistant S. sonnei and is capable of establishing endemic transmission in new locations. Despite being limited in geographical scope, our work has major implications for understanding the international transfer of antimicrobial-resistant pathogens, with S. sonnei acting as a tractable model for studying how antimicrobial-resistant Gram-negative bacteria spread globally.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Ciprofloxacin/therapeutic use , Dysentery, Bacillary/drug therapy , Shigella sonnei/drug effects , Australia/epidemiology , Bhutan/epidemiology , Cambodia/epidemiology , Child, Preschool , Cross-Sectional Studies , Drug Resistance, Bacterial/genetics , Drug Resistance, Multiple, Bacterial/genetics , Dysentery, Bacillary/epidemiology , Dysentery, Bacillary/microbiology , Genome, Bacterial/genetics , Humans , Ireland/epidemiology , Phylogeny , Shigella sonnei/genetics , Thailand/epidemiology , Vietnam/epidemiology
2.
J Antimicrob Chemother ; 71(8): 2314-7, 2016 08.
Article in English | MEDLINE | ID: mdl-27246235

ABSTRACT

OBJECTIVES: The objective of this study was to assess the presence of mcr-1 in Shigella sonnei isolated in Vietnam. METHODS: WGS data were analysed for the presence of the mcr-1 gene sequence. The association of mcr-1 with a plasmid was assessed by PCR and by conjugation. RESULTS: Through genome sequencing we identified a plasmid-associated inactive form of mcr-1 in a 2008 Vietnamese isolate of Shigella sonnei. The plasmid was conjugated into Escherichia coli and mcr-1 was activated upon exposure to colistin, resulting in highly colistin-resistant transconjugants. CONCLUSIONS: This is the first description of the mcr-1 gene in Shigella, which is atypical given that colistin is not ordinarily used to treat diarrhoea. Our data suggest the mcr-1 gene has been circulating in human-restricted pathogens for some time but likely carries a selective fitness cost.


Subject(s)
Anti-Bacterial Agents/pharmacology , Colistin/pharmacology , Drug Resistance, Bacterial , Gene Expression Regulation, Bacterial , Genes, Bacterial , Plasmids , Shigella sonnei/drug effects , Conjugation, Genetic , Gene Transfer, Horizontal , Genome, Bacterial , Humans , Polymerase Chain Reaction , Sequence Analysis, DNA , Shigella sonnei/genetics , Shigella sonnei/isolation & purification , Transcriptional Activation , Vietnam
3.
PLoS Negl Trop Dis ; 18(6): e0011864, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38889189

ABSTRACT

Salmonella Paratyphi A, one of the major etiologic agents of enteric fever, has increased in prevalence in recent decades in certain endemic regions in comparison to S. Typhi, the most prevalent cause of enteric fever. Despite this increase, data on the prevalence and molecular epidemiology of S. Paratyphi A remain generally scarce. Here, we analysed the whole genome sequences of 216 S. Paratyphi A isolates originating from Kathmandu, Nepal between 2005 and 2014, of which 200 were from patients with acute enteric fever and 16 from the gallbladder of people with suspected chronic carriage. By exploiting the recently developed genotyping framework for S. Paratyphi A (Paratype), we identified several genotypes circulating in Kathmandu. Notably, we observed an unusual clonal expansion of genotype 2.4.3 over a four-year period that spread geographically and systematically replaced other genotypes. This rapid genotype replacement is hypothesised to have been driven by both reduced susceptibility to fluoroquinolones and genetic changes to virulence factors, such as functional and structural genes encoding the type 3 secretion systems. Finally, we show that person-to-person is likely the most common mode of transmission and chronic carriers seem to play a limited role in maintaining disease circulation.


Subject(s)
Genotype , Paratyphoid Fever , Salmonella paratyphi A , Nepal/epidemiology , Humans , Salmonella paratyphi A/genetics , Salmonella paratyphi A/isolation & purification , Salmonella paratyphi A/classification , Retrospective Studies , Paratyphoid Fever/epidemiology , Paratyphoid Fever/microbiology , Male , Adult , Female , Young Adult , Adolescent , Child , Prevalence , Middle Aged , Molecular Epidemiology , Child, Preschool , Whole Genome Sequencing , Anti-Bacterial Agents/pharmacology , Phylogeny
4.
Commun Biol ; 7(1): 775, 2024 Jun 28.
Article in English | MEDLINE | ID: mdl-38942806

ABSTRACT

Antimicrobial resistance (AMR) poses a serious threat to the clinical management of typhoid fever. AMR in Salmonella Typhi (S. Typhi) is commonly associated with the H58 lineage, a lineage that arose comparatively recently before becoming globally disseminated. To better understand when and how H58 emerged and became dominant, we performed detailed phylogenetic analyses on contemporary genome sequences from S. Typhi isolated in the period spanning the emergence. Our dataset, which contains the earliest described H58 S. Typhi organism, indicates that ancestral H58 organisms were already multi-drug resistant (MDR). These organisms emerged spontaneously in India in 1987 and became radially distributed throughout South Asia and then globally in the ensuing years. These early organisms were associated with a single long branch, possessing mutations associated with increased bile tolerance, suggesting that the first H58 organism was generated during chronic carriage. The subsequent use of fluoroquinolones led to several independent mutations in gyrA. The ability of H58 to acquire and maintain AMR genes continues to pose a threat, as extensively drug-resistant (XDR; MDR plus resistance to ciprofloxacin and third generation cephalosporins) variants, have emerged recently in this lineage. Understanding where and how H58 S. Typhi originated and became successful is key to understand how AMR drives successful lineages of bacterial pathogens. Additionally, these data can inform optimal targeting of typhoid conjugate vaccines (TCVs) for reducing the potential for emergence and the impact of new drug-resistant variants. Emphasis should also be placed upon the prospective identification and treatment of chronic carriers to prevent the emergence of new drug resistant variants with the ability to spread efficiently.


Subject(s)
Anti-Bacterial Agents , Phylogeny , Salmonella typhi , Typhoid Fever , Salmonella typhi/genetics , Salmonella typhi/drug effects , Typhoid Fever/microbiology , Typhoid Fever/drug therapy , Typhoid Fever/epidemiology , Humans , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/genetics , Haplotypes , Mutation , Genome, Bacterial
5.
J Clin Microbiol ; 51(9): 2950-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23824765

ABSTRACT

Salmonella enterica serovar Typhi, the causative agent of typhoid fever, is highly clonal and genetically conserved, making isolate subtyping difficult. We describe a standardized multiplex ligation-dependent probe amplification (MLPA) genotyping scheme targeting 11 key phylogenetic markers of the S. Typhi genome. The MLPA method demonstrated 90% concordance with single nucleotide polymorphism (SNP) typing, the gold standard for S. Typhi genotyping, and had the ability to identify isolates of the H58 haplotype, which is associated with resistance to multiple antimicrobials. Additionally, the assay permitted the detection of fluoroquinolone resistance-associated mutations in the DNA gyrase-encoding gene gyrA and the topoisomerase gene parC with a sensitivity of 100%. The MLPA methodology is simple and reliable, providing phylogenetically and phenotypically relevant genotyping information. This MLPA scheme offers a more-sensitive and interpretable alternative to the nonphylogenetic subgrouping methodologies that are currently used in reference and research laboratories in areas where typhoid is endemic.


Subject(s)
Molecular Typing/methods , Multiplex Polymerase Chain Reaction/methods , Polymorphism, Genetic , Salmonella typhi/classification , Salmonella typhi/genetics , Drug Resistance, Bacterial , Genes, Bacterial , Genotype , Humans , Sensitivity and Specificity , Time Factors
6.
Nat Commun ; 10(1): 4828, 2019 10 23.
Article in English | MEDLINE | ID: mdl-31645551

ABSTRACT

Shigella sonnei increasingly dominates the international epidemiological landscape of shigellosis. Treatment options for S. sonnei are dwindling due to resistance to several key antimicrobials, including the fluoroquinolones. Here we analyse nearly 400 S. sonnei whole genome sequences from both endemic and non-endemic regions to delineate the evolutionary history of the recently emergent fluoroquinolone-resistant S. sonnei. We reaffirm that extant resistant organisms belong to a single clonal expansion event. Our results indicate that sequential accumulation of defining mutations (gyrA-S83L, parC-S80I, and gyrA-D87G) led to the emergence of the fluoroquinolone-resistant S. sonnei population around 2007 in South Asia. This clone was then transmitted globally, resulting in establishments in Southeast Asia and Europe. Mutation analysis suggests that the clone became dominant through enhanced adaptation to oxidative stress. Experimental evolution reveals that under fluoroquinolone exposure in vitro, resistant S. sonnei develops further intolerance to the antimicrobial while the susceptible counterpart fails to attain complete resistance.


Subject(s)
Drug Resistance, Bacterial/genetics , Dysentery, Bacillary/microbiology , Fluoroquinolones , Genome, Bacterial/genetics , Shigella sonnei/genetics , Anti-Bacterial Agents/therapeutic use , Asia, Southeastern/epidemiology , Asia, Western/epidemiology , Bayes Theorem , Ciprofloxacin/therapeutic use , DNA Gyrase/genetics , DNA Topoisomerase IV/genetics , Directed Molecular Evolution , Dysentery, Bacillary/drug therapy , Dysentery, Bacillary/epidemiology , Europe/epidemiology , Evolution, Molecular , Humans , Molecular Epidemiology , Mutation , Phylogeny , Polymorphism, Single Nucleotide , Shigella sonnei/physiology
7.
Gut Microbes ; 9(1): 38-54, 2018 01 02.
Article in English | MEDLINE | ID: mdl-28767339

ABSTRACT

Diarrheal diseases remain the second most common cause of mortality in young children in developing countries. Efforts have been made to explore the impact of diarrhea on bacterial communities in the human gut, but a thorough understanding has been impeded by inadequate resolution in bacterial identification and the examination of only few etiological agents. Here, by profiling an extended region of the 16S rRNA gene in the fecal microbiome, we aimed to elucidate the nature of gut microbiome perturbations during the early phase of infectious diarrhea caused by various etiological agents in Vietnamese children. Fecal samples from 145 diarrheal cases with a confirmed infectious etiology before antimicrobial therapy and 54 control subjects were analyzed. We found that the diarrheal fecal microbiota could be robustly categorized into 4 microbial configurations that either generally resembled or were highly divergent from a healthy state. Factors such as age, nutritional status, breastfeeding, and the etiology of the infection were significantly associated with these microbial community structures. We observed a consistent elevation of Fusobacterium mortiferum, Escherichia, and oral microorganisms in all diarrheal fecal microbiome configurations, proposing similar mechanistic interactions, even in the absence of global dysbiosis. We additionally found that Bifidobacterium pseudocatenulatum was significantly depleted during dysenteric diarrhea regardless of the etiological agent, suggesting that further investigations into the use of this species as a dysentery-orientated probiotic therapy are warranted. Our findings contribute to the understanding of the complex influence of infectious diarrhea on gut microbiome and identify new opportunities for therapeutic interventions.


Subject(s)
Bacterial Physiological Phenomena , Diarrhea, Infantile/microbiology , Gastrointestinal Microbiome , Gastrointestinal Tract/microbiology , Bacteria/classification , Bacteria/genetics , Biodiversity , Cluster Analysis , Diarrhea, Infantile/virology , Dysbiosis/microbiology , Dysentery/microbiology , Dysentery/virology , Feces/microbiology , Feces/virology , Female , Gastrointestinal Tract/virology , Humans , Infant , Male , RNA, Ribosomal, 16S/genetics , Risk Factors , Vietnam
8.
J Infect ; 75(2): 104-114, 2017 08.
Article in English | MEDLINE | ID: mdl-28551371

ABSTRACT

OBJECTIVES: The diagnosis of typhoid fever is a challenge. Aiming to develop a typhoid diagnostic we measured antibody responses against Salmonella Typhi (S. Typhi) protein antigens and the Vi polysaccharide in a cohort of Bangladeshi febrile patients. METHODS: IgM against 12 purified antigens and the Vi polysaccharide was measured by ELISA in plasma from patients with confirmed typhoid fever (n = 32), other confirmed infections (n = 17), and healthy controls (n = 40). ELISAs with the most specific antigens were performed on plasma from 243 patients with undiagnosed febrile disease. RESULTS: IgM against the S. Typhi protein antigens correlated with each other (rho > 0.8), but not against Vi (rho < 0.6). Typhoid patients exhibited higher IgM against 11/12 protein antigens and Vi than healthy controls and those with other infections. Vi, PilL, and CdtB exhibited the greatest sensitivity and specificity. Specificity and sensitivity was improved when Vi was combined with a protein antigen, generating sensitivities and specificities of 0.80 and >0.85, respectively. Applying a dynamic cut-off to patients with undiagnosed febrile disease suggested that 34-58% had an IgM response indicative of typhoid. CONCLUSIONS: We evaluated the diagnostic potential of several S. Typhi antigens; our assays give good sensitivity and specificity, but require further assessment in differing patient populations.


Subject(s)
Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Bacteriological Techniques/methods , Salmonella typhi/immunology , Typhoid Fever/diagnosis , Bangladesh , Humans , Immunoglobulin M/blood , Polysaccharides, Bacterial/immunology , Typhoid Fever/immunology
9.
PLoS Negl Trop Dis ; 10(6): e0004785, 2016 06.
Article in English | MEDLINE | ID: mdl-27331909

ABSTRACT

Typhoid fever, caused by the bacterium Salmonella Typhi, is an endemic cause of febrile disease in Cambodia. The aim of this study was to better understand the epidemiology of pediatric typhoid fever in Cambodia. We accessed routine blood culture data from Angkor Hospital for Children (AHC) in Siem Reap province between 2007 and 2014, and performed whole genome sequencing (WGS) on the isolated bacteria to characterize the S. Typhi population. The resulting phylogenetic information was combined with conventional epidemiological approaches to investigate the spatiotemporal distribution of S. Typhi and population-level risk factors for reported disease. During the study period, there were 262 cases of typhoid within a 100 km radius of AHC, with a median patient age of 8.2 years (IQR: 5.1-11.5 years). The majority of infections occurred during the rainy season, and commune incidences as high as 11.36/1,000 in children aged <15 years were observed over the study period. A population-based risk factor analysis found that access to water within households and increasing distance from Tonle Sap Lake were protective. Spatial mapping and WGS provided additional resolution for these findings, and confirmed that proximity to the lake was associated with discrete spatiotemporal disease clusters. We confirmed the dominance of MDR H58 S. Typhi in this population, and found substantial evidence of diversification (at least seven sublineages) within this single lineage. We conclude that there is a substantial burden of pediatric typhoid fever in rural communes in Cambodia. Our data provide a platform for additional population-based typhoid fever studies in this location, and suggest that this would be a suitable setting in which to introduce a school-based vaccination programme with Vi conjugate vaccines.


Subject(s)
Molecular Epidemiology , Rural Population , Salmonella typhi/genetics , Typhoid Fever/epidemiology , Typhoid Fever/microbiology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cambodia/epidemiology , Child , Child, Preschool , Haplotypes , Humans , Phylogeny , Polymorphism, Single Nucleotide , Risk Factors , Seasons , Time Factors
10.
PLoS Negl Trop Dis ; 10(1): e0004346, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26735696

ABSTRACT

One of the UN sustainable development goals is to achieve universal access to safe and affordable drinking water by 2030. It is locations like Kathmandu, Nepal, a densely populated city in South Asia with endemic typhoid fever, where this goal is most pertinent. Aiming to understand the public health implications of water quality in Kathmandu we subjected weekly water samples from 10 sources for one year to a range of chemical and bacteriological analyses. We additionally aimed to detect the etiological agents of typhoid fever and longitudinally assess microbial diversity by 16S rRNA gene surveying. We found that the majority of water sources exhibited chemical and bacterial contamination exceeding WHO guidelines. Further analysis of the chemical and bacterial data indicated site-specific pollution, symptomatic of highly localized fecal contamination. Rainfall was found to be a key driver of this fecal contamination, correlating with nitrates and evidence of S. Typhi and S. Paratyphi A, for which DNA was detectable in 333 (77%) and 303 (70%) of 432 water samples, respectively. 16S rRNA gene surveying outlined a spectrum of fecal bacteria in the contaminated water, forming complex communities again displaying location-specific temporal signatures. Our data signify that the municipal water in Kathmandu is a predominant vehicle for the transmission of S. Typhi and S. Paratyphi A. This study represents the first extensive spatiotemporal investigation of water pollution in an endemic typhoid fever setting and implicates highly localized human waste as the major contributor to poor water quality in the Kathmandu Valley.


Subject(s)
Feces/microbiology , Salmonella paratyphi A/isolation & purification , Salmonella typhi/isolation & purification , Water Microbiology , Water Supply/standards , Cities , DNA, Bacterial/genetics , Humans , Nepal , Paratyphoid Fever/epidemiology , Paratyphoid Fever/microbiology , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics , Real-Time Polymerase Chain Reaction , Typhoid Fever/epidemiology , Typhoid Fever/microbiology
11.
Microb Genom ; 2(3): e000050, 2016 03.
Article in English | MEDLINE | ID: mdl-28348846

ABSTRACT

We recently reported a dramatic increase in the prevalence of carbapenem-resistant Acinetobacter baumannii infections in the intensive care unit (ICU) of a Vietnamese hospital. This upsurge was associated with a specific oxa23-positive clone that was identified by multilocus VNTR analysis. Here, we used whole-genome sequence analysis to dissect the emergence of carbapenem-resistant A. baumannii causing ventilator-associated pneumonia (VAP) in the ICU during 2009-2012. To provide historical context and distinguish microevolution from strain introduction, we compared these genomes with those of A. baumannii asymptomatic carriage and VAP isolates from this same ICU collected during 2003-2007. We identified diverse lineages co-circulating over many years. Carbapenem resistance was associated with the presence of oxa23, oxa40, oxa58 and ndm1 genes in multiple lineages. The majority of resistant isolates were oxa23-positive global clone GC2; fine-scale phylogenomic analysis revealed five distinct GC2 sublineages within the ICU that had evolved locally via independent chromosomal insertions of oxa23 transposons. The increase in infections caused by carbapenem-resistant A. baumannii was associated with transposon-mediated transmission of a carbapenemase gene, rather than clonal expansion or spread of a carbapenemase-harbouring plasmid. Additionally, we found evidence of homologous recombination creating diversity within the local GC2 population, including several events resulting in replacement of the capsule locus. We identified likely donors of the imported capsule locus sequences amongst the A. baumannii isolated on the same ward, suggesting that diversification was largely facilitated via reassortment and sharing of genetic material within the localized A. baumannii population.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter Infections/microbiology , Acinetobacter baumannii/classification , Acinetobacter baumannii/physiology , Pneumonia, Ventilator-Associated/microbiology , Acinetobacter baumannii/genetics , Carbapenems , Drug Resistance, Bacterial/genetics , Evolution, Molecular , Genes, Bacterial/genetics , Genetic Variation , Genome, Bacterial/genetics , Humans , Phylogeny , Recombination, Genetic , Vietnam/epidemiology , Whole Genome Sequencing
12.
Elife ; 5: e14003, 2016 Mar 11.
Article in English | MEDLINE | ID: mdl-26974227

ABSTRACT

The interplay between bacterial antimicrobial susceptibility, phylogenetics and patient outcome is poorly understood. During a typhoid clinical treatment trial in Nepal, we observed several treatment failures and isolated highly fluoroquinolone-resistant Salmonella Typhi (S. Typhi). Seventy-eight S. Typhi isolates were genome sequenced and clinical observations, treatment failures and fever clearance times (FCTs) were stratified by lineage. Most fluoroquinolone-resistant S. Typhi belonged to a specific H58 subclade. Treatment failure with S. Typhi-H58 was significantly less frequent with ceftriaxone (3/31; 9.7%) than gatifloxacin (15/34; 44.1%)(Hazard Ratio 0.19, p=0.002). Further, for gatifloxacin-treated patients, those infected with fluoroquinolone-resistant organisms had significantly higher median FCTs (8.2 days) than those infected with susceptible (2.96) or intermediately resistant organisms (4.01)(pS. Typhi clade internationally, but there are no data regarding disease outcome with this organism. We report an emergent new subclade of S. Typhi-H58 that is associated with fluoroquinolone treatment failure.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Ciprofloxacin/pharmacology , Fluoroquinolones/therapeutic use , Genotype , Salmonella typhi/drug effects , Typhoid Fever/drug therapy , Bacterial Typing Techniques , Ceftriaxone/therapeutic use , Gatifloxacin , Humans , Nepal , Salmonella typhi/classification , Salmonella typhi/isolation & purification , Sequence Analysis, DNA , Treatment Failure , Typhoid Fever/microbiology
13.
Elife ; 4: e07335, 2015 Aug 04.
Article in English | MEDLINE | ID: mdl-26238191

ABSTRACT

Shigella flexneri is the most common cause of bacterial dysentery in low-income countries. Despite this, S. flexneri remains largely unexplored from a genomic standpoint and is still described using a vocabulary based on serotyping reactions developed over half-a-century ago. Here we combine whole genome sequencing with geographical and temporal data to examine the natural history of the species. Our analysis subdivides S. flexneri into seven phylogenetic groups (PGs); each containing two-or-more serotypes and characterised by distinct virulence gene complement and geographic range. Within the S. flexneri PGs we identify geographically restricted sub-lineages that appear to have persistently colonised regions for many decades to over 100 years. Although we found abundant evidence of antimicrobial resistance (AMR) determinant acquisition, our dataset shows no evidence of subsequent intercontinental spread of antimicrobial resistant strains. The pattern of colonisation and AMR gene acquisition suggest that S. flexneri has a distinct life-cycle involving local persistence.


Subject(s)
Dysentery, Bacillary/epidemiology , Dysentery, Bacillary/microbiology , Genetic Variation , Genome, Bacterial , Phylogeography , Shigella flexneri/classification , Shigella flexneri/genetics , Drug Resistance, Bacterial , Global Health , Humans , Molecular Epidemiology , Molecular Sequence Data , Sequence Analysis, DNA , Serogroup , Spatio-Temporal Analysis , Virulence Factors/genetics
14.
EMBO Mol Med ; 7(3): 227-39, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25712531

ABSTRACT

Multidrug-resistant (MDR) Klebsiella pneumoniae has become a leading cause of nosocomial infections worldwide. Despite its prominence, little is known about the genetic diversity of K. pneumoniae in resource-poor hospital settings. Through whole-genome sequencing (WGS), we reconstructed an outbreak of MDR K. pneumoniae occurring on high-dependency wards in a hospital in Kathmandu during 2012 with a case-fatality rate of 75%. The WGS analysis permitted the identification of two MDR K. pneumoniae lineages causing distinct outbreaks within the complex endemic K. pneumoniae. Using phylogenetic reconstruction and lineage-specific PCR, our data predicted a scenario in which K. pneumoniae, circulating for 6 months before the outbreak, underwent a series of ward-specific clonal expansions after the acquisition of genes facilitating virulence and MDR. We suggest that the early detection of a specific NDM-1 containing lineage in 2011 would have alerted the high-dependency ward staff to intervene. We argue that some form of real-time genetic characterisation, alongside clade-specific PCR during an outbreak, should be factored into future healthcare infection control practices in both high- and low-income settings.


Subject(s)
Cross Infection/epidemiology , Disease Outbreaks , Drug Resistance, Multiple, Bacterial , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/classification , Klebsiella pneumoniae/genetics , Animals , Cluster Analysis , Cross Infection/microbiology , Evolution, Molecular , Genes, Bacterial , Genome, Bacterial , Genomics , Genotype , Humans , Infection Control/methods , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Mice , Molecular Sequence Data , Nepal/epidemiology , Phylogeny , Polymerase Chain Reaction , Sequence Analysis, DNA , Sequence Homology , Virulence Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL